Hartwig Huland Selected Research

Hartwig Huland Research Topics

Disease

206	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 02/2002
122	Neoplasms (Cancer) 01/2022 - 02/2002
30	Margins of Excision 01/2022 - 04/2003
25	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2004
12	Lymphatic Metastasis 01/2021 - 11/2003
12	Carcinoma (Carcinomatosis) 01/2017 - 08/2002
10	Extranodal Extension 11/2017 - 02/2004
7	Urinary Bladder Neoplasms (Bladder Cancer) 05/2011 - 06/2004
5	Urinary Incontinence 11/2020 - 05/2011
4	Genomic Instability 01/2021 - 01/2020
4	7 Hereditary Prostate Cancer 07/2020 - 09/2017
4	Transitional Cell Carcinoma 09/2006 - 12/2004
4	Prostatic Diseases 05/2006 - 11/2002
3	Obesity 07/2018 - 08/2007
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2008 - 12/2003
2	Erectile Dysfunction 01/2017 - 04/2007
2	Prostatic Intraepithelial Neoplasia 03/2010 - 12/2008
1	Circulating Neoplastic Cells 01/2021
1	Second Primary Neoplasms (Neoplasms, Second) 05/2020
1	Small Cell Carcinoma 09/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Fistula 01/2018
1	Wounds and Injuries (Trauma) 01/2018

Drug/Important Bio-Agent (IBA)

69	Prostate-Specific Antigen (Semenogelase)IBA 12/2021 - 03/2002
25	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2004
18	Biomarkers (Surrogate Marker)IBA 07/2020 - 11/2003
10	AndrogensIBA 01/2022 - 11/2003
9	AntigensIBA 12/2021 - 06/2004
8	Biological ProductsIBA 01/2021 - 11/2003
8	DNA (Deoxyribonucleic Acid)IBA 08/2020 - 11/2004
7	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 12/2014
6	Hormones (Hormone)IBA 01/2021 - 02/2004
6	Tissue Kallikreins (Tissue Kallikrein)IBA 02/2007 - 02/2003
5	TensinsIBA 01/2020 - 12/2014
4	Serine Proteases (Serine Protease)IBA 01/2020 - 12/2014
4	Messenger RNA (mRNA)IBA 01/2020 - 03/2002
4	Capsules (Microcapsules)IBA 11/2019 - 06/2006
4	nuclear matrix protein 22IBA 09/2006 - 08/2002
3	Androgen Receptors (Androgen Receptor)IBA 12/2019 - 01/2019
3	isopropyl cyanoacrylateIBA 01/2015 - 08/2008
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 09/2004
2	Kallikreins (Kallikrein)IBA 01/2020 - 04/2009
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2018
2	CEACAM1 ProteinIBA 01/2020 - 12/2004
2	SurvivinIBA 01/2020 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2019 - 06/2008
2	Dihydrotachysterol (AT 10)IBA 11/2017 - 07/2013
2	Histones (Histone)IBA 11/2015 - 06/2015
2	Indicators and Reagents (Reagents)IBA 07/2015 - 03/2002
2	Cell-Free Nucleic AcidsIBA 05/2011 - 09/2006
2	AntibodiesIBA 03/2010 - 06/2004
2	Protein Isoforms (Isoforms)IBA 04/2007 - 06/2004
2	Fluconazole (Zonal)FDA LinkGeneric 04/2007 - 07/2003
2	polyurethane-polypropylene composite (TMS 1)IBA 11/2005 - 11/2004
2	RNA (Ribonucleic Acid)IBA 09/2005 - 03/2002
2	Monoclonal AntibodiesIBA 06/2004 - 08/2002
1	AnoctaminsIBA 01/2021
1	gamma Catenin (Plakoglobin)IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	CateninsIBA 01/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2020
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 11/2020
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 11/2020
1	WD repeat containing planar cell polarity effectorIBA 10/2020
1	Claudin-1IBA 09/2020
1	Abiraterone AcetateIBA 08/2020
1	Androgen Antagonists (Antiandrogens)IBA 08/2020
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 08/2020
1	indatuximab ravtansineIBA 01/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	CCCTC-Binding FactorIBA 01/2020
1	Proto-Oncogene Proteins c-etsIBA 11/2019
1	Protein Tyrosine PhosphatasesIBA 10/2019
1	Tyrosine (L-Tyrosine)FDA Link 10/2019
1	Amino Acids FDA Link 05/2019
1	Glycogen Synthase KinasesIBA 03/2019
1	taxaneIBA 03/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 03/2019
1	CCAAT-Enhancer-Binding Protein-alphaIBA 01/2019
1	centromere protein FIBA 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Proteoglycans (Proteoglycan)IBA 09/2017
1	BiglycanIBA 09/2017

Therapy/Procedure

141	Prostatectomy (Retropubic Prostatectomy) 10/2022 - 02/2002
25	Therapeutics 01/2022 - 11/2003
13	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 02/2002
12	Radiotherapy 10/2022 - 11/2003
5	Castration 01/2021 - 04/2009
3	Adjuvant Radiotherapy 01/2022 - 03/2008
2	Catheters 01/2019 - 07/2014
2	Salvage Therapy 12/2017 - 11/2003
2	Lasers (Laser) 05/2014 - 09/2005
2	Chemoprevention 12/2007 - 10/2007
1	Combined Modality Therapy 01/2020
1	Length of Stay 01/2019
1	Transplantation 12/2018
1	Operative Surgical Procedures 01/2018
1	Enterostomy 01/2018
1	Aftercare (After-Treatment) 09/2017
1	Brachytherapy 05/2017